SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Risk Assessment in Injectable Manufacturing – V 2.0

Sterile Injectable Manufacturing: SOP for Risk Assessment in Injectable Manufacturing – V 2.0

Standard Operating Procedure for Risk Assessment in Injectable Manufacturing

Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/085/2025
Supersedes SOP/SIM/085/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP provides a systematic approach to risk assessment in sterile injectable manufacturing. It ensures potential risks to product quality, patient safety, and regulatory compliance are proactively identified, analyzed, mitigated, and documented using scientific and process-based rationale.

2. Scope

This SOP applies to all critical operations, processes, equipment, materials, utilities, and documentation systems used in the sterile injectable manufacturing facility.

3. Responsibilities

  • Department Heads: Identify areas and processes requiring risk assessment.
  • QA Representative: Facilitate and coordinate risk assessment activities.
  • Risk
Assessment Team: Participate in risk evaluation and develop mitigation strategies.
  • QA Manager: Review and approve the risk assessment report and actions.
  • 4. Accountability

    The Head – Quality Assurance is accountable for ensuring compliance with this SOP and the effective execution of risk assessment procedures across all sterile injectable operations.

    5. Procedure

    5.1 Risk Assessment Planning

    1. Define the purpose and scope of the risk assessment (e.g., new equipment, process change, deviation analysis, etc.).
    2. Appoint a cross-functional team comprising QA, Production, Engineering, QC, and Regulatory Affairs.
    3. Prepare a Risk Assessment Plan (Annexure-1).

    5.2 Risk Identification

    1. Use tools such as Process Flow Diagrams, Cause-and-Effect (Fishbone) Diagrams, and Brainstorming sessions.
    2. Document all potential hazards, failure points, or deviations from predefined quality attributes or process parameters.
    3. Record identified risks in the Risk Register (Annexure-2).

    5.3 Risk Analysis

    1. Analyze the severity (S), probability (P), and detectability (D) of each risk using a scoring scale (e.g., 1–5).
    2. Calculate Risk Priority Number (RPN): RPN = S × P × D.
    3. Rank risks based on RPN value.

    5.4 Risk Evaluation and Control

    1. Classify risks as Low, Medium, or High based on predefined RPN thresholds.
    2. Determine appropriate control actions:
      • Elimination of the risk source
      • Substitution with a safer method
      • Implementation of engineering or administrative controls
    3. Record mitigation strategy in Risk Control Sheet (Annexure-3).

    5.5 Risk Mitigation and Implementation

    1. Assign responsible personnel and deadlines for risk mitigation actions.
    2. Monitor implementation progress.
    3. Verify effectiveness through impact assessments or validation reports.

    5.6 Risk Review and Approval

    1. Compile a Risk Assessment Report summarizing the process, findings, mitigation measures, and outcomes (Annexure-4).
    2. QA reviews and approves the final document.
    3. Maintain records for audit and regulatory submission.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • RPN: Risk Priority Number
    • FMEA: Failure Mode and Effects Analysis
    • PFD: Process Flow Diagram

    7. Documents

    1. Risk Assessment Plan – Annexure-1
    2. Risk Register – Annexure-2
    3. Risk Control Sheet – Annexure-3
    4. Risk Assessment Report – Annexure-4

    8. References

    • ICH Q9 – Quality Risk Management
    • WHO TRS 986 Annex 2 – GMP Guidelines
    • ISO 31000: Risk Management – Principles and Guidelines

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation Manufacturing Executive QA Executive Head QA
    Department Production Quality Assurance Quality Assurance

    11. Annexures

    Annexure-1: Risk Assessment Plan

    Area Filling Line (SVP)
    Purpose New Equipment Installation
    Date 01/06/2025
    Team Members Sunita Reddy, Rajesh Kumar, Anita Mehta

    Annexure-2: Risk Register

    Risk ID Description Severity Probability Detectability RPN
    R001 Power failure during filling 5 4 3 60

    Annexure-3: Risk Control Sheet

    Risk ID Control Strategy Owner Deadline Status
    R001 UPS system installation Engineering 15/06/2025 Completed

    Annexure-4: Risk Assessment Report

    Report No. RAR/2025/015
    Summary Risk assessment conducted for SVP filling line installation. One high-risk and two medium-risk issues identified and mitigated. No unacceptable risk remains.
    Approved By QA Head
    Approval Date 16/06/2025

    Revision History

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial Issue New SOP QA Head
    18/06/2025 2.0 Revised structure, updated annexures Periodic Review QA Head
    Exit mobile version